TIAM
ABBV icon

TT International Asset Management’s AbbVie ABBV Stock Holding History

TT International Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,500
Closed -$1.75M – 66
2021
Q2 		$1.75M Hold
15,500
– – 0.08% 48
2021
Q1 		$1.68K Hold
15,500
– – 0.07% 43
2020
Q4 		$1.66M Buy
+15,500
New +$1.49M 0.08% 45

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TT International Asset Management's ABBV Position: Q3 2021 in Review

TT International Asset Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 15,500 shares — an estimated $1.75M sold.

TT International Asset Management first reported a position in ABBV in Q4 2020 and held it in 3 quarters. The position peaked at $1.75M in Q2 2021. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • TT International Asset Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
  • TT International Asset Management sold 15,500 AbbVie shares in Q3 2021, an estimated $1.75M.
  • TT International Asset Management first reported a position in AbbVie in Q4 2020 and held it in 3 quarters.
  • TT International Asset Management's AbbVie position peaked at $1.75M in Q2 2021.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on TT International Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.